Last update 16 May 2025

SCM-02-138

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
SCM-02-138
Target
MALT1
Action
inhibitors
Mechanism
MALT1 inhibitors(Mucosa-associated lymphoid tissue lymphoma translocation protein 1 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication
Diffuse Large B-Cell Lymphoma
Inactive Indication-
Originator Organization
Janssen Pharmaceutica NVJanssen Pharmaceutica NV
Active Organization
The Children's Hospital Corp.The Children's Hospital Corp.Janssen Pharmaceutica NVJanssen Pharmaceutica NVWeill Medical College of Cornell UniversityWeill Medical College of Cornell University
+ [1]
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with SCM-02-138
Login to view more data
100 Translational Medicine associated with SCM-02-138
Login to view more data
100 Patents (Medical) associated with SCM-02-138
Login to view more data
100 Deals associated with SCM-02-138
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diffuse Large B-Cell LymphomaPreclinical
United States
The Children's Hospital Corp.The Children's Hospital Corp.
-
Diffuse Large B-Cell LymphomaPreclinical
United States
Dana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.
-
Diffuse Large B-Cell LymphomaPreclinical
United States
Weill Medical College of Cornell UniversityWeill Medical College of Cornell University
-
Diffuse Large B-Cell LymphomaPreclinical
Belgium
Janssen Pharmaceutica NVJanssen Pharmaceutica NV
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free